Expression of human (transgene under the Thy-1 promoter) and mouse APP were both down-regulated at the mRNA level (Fig. 6B left panel) in 3xTg-AD mice treated with AAV-NF-α1/CPE. The gene discussed is THY1; the disease is Alzheimer disease.